The National Community Oncology Dispensing Association has announced the addition of hematologist and medical oncologist Barry D. Brooks, MD, to its executive council in April.
Barry D. Brooks, MD
The National Community Oncology Dispensing Association (NCODA) has announced the addition of hematologist and medical oncologist Barry D. Brooks, MD, to its executive council in April.
“Being part of NCODA is a great honor. I believe NCODA will do for oncology dispensing what the Community Oncology Alliance has done for community oncology by improving access to oral oncology drugs for America’s cancer patients and giving patients a voice in Washington,” said Brooks.
For the past 17 years, Brooks, a clinical associate professor at the University of Texas Health Science Center, Texas Oncology, has been a physician-lead on US Oncology’s Drug Contracting Committee. Additionally, he served as chair of Pharmacy and Therapeutics at US Oncology from 2011 to 2018 and currently serves as Medical Director of Oral Oncolytics.
Brooks received his medical degree from the University of Texas Southwestern Medical School and did his medical residency in internal medicine, as well as a hematology/oncology fellowship, with Parkland Memorial Hospital and Dallas VA Hospital.
“Dr Brooks, in addition to being an outstanding medical oncologist, is a dynamic individual who will bring a great deal of insight from a physician’s perspective to our NCODA initiatives” said Jim Schwartz, NCODA President and Executive Council Chair.